David Triggle, Ph.D. explains hERG (human Ether-à-go-go Related Gene) during ResMed 2013. Dr. Triggle’s research includes mechanisms of actions of ion channels and pharmacological receptors; intellectual property issues; educational policies; research ethics. Dr. Triggle has been lecturing for ResMed since its first year: 1987.
Vincent Stoll, Ph.D. of Abbvie explains the optimization of drug properties during his 2013 ResMed lecture. Dr. Stoll’s 3D slides kept attendees engaged throughout his presentation entitled, “Drug Design Using Structural Biology” .
(Once you click on a photo, you can use the arrow keys to scroll through)